INSEMA from SABCS 2024 – No Axillary Surgery vs. Axillary SLNB in Early-Stage HR+ Breast Cancer
Автор: OncUpdates: Latest Oncology Insights
Загружено: 2025-01-21
Просмотров: 1035
Welcome to another episode of the Oncology Brothers podcast! In this episode, hosts Drs. Rahul & Rohit Gosain are joined by Dr. Laura Huppert from UCSF to discuss key highlights from the San Antonio Breast Cancer Symposium 2024.
We delved into the INSEMA Study, which explored the potential to omit axillary surgery in early-stage hormone receptor-positive breast cancer patients. Dr. Huppert explained that this large randomized trial found no significant difference in invasive disease-free survival between patients who underwent sentinel lymph node biopsy and those who did not. Importantly, patients who skipped surgery reported fewer complications and better quality of life. However, we noted the need for longer follow-up to fully understand the implications of this approach, especially considering the potential for undetected positive nodes.
Full Podcast: • SABCS 2024 Highlights - INSEMA, KEYNOTE-52...
Main Channel: / @oncologybrothers
Don't forget to like, subscribe, and check out more episodes for in-depth discussions on oncology topics!
Website: http://www.oncbrothers.com/
X/Twitter: / oncbrothers
Contact us at info@oncbrothers.com
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
